Jason Ng is an Endocrinology/Metabolic physician affiliated with University of Pittsburgh Medical Center. OpenAlex indexes 20 publications with 246 citations (h-index 7); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
- Utilizing a Novel Method to Map Sources of Atrial Fibrillation
Sponsor: Northwestern University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year20243 payments
- PFIZER INC.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
65.7%Insulin Analog23.5%Lantus Solostar30%Humalog Kwikpen U-10017%Toujeo Max Solostar14%Novolog Flexpen12%Tresiba Flextouch U-1006%Tresiba Flextouch U-2006%Basaglar Kwikpen U-1005%Novolog4%Toujeo Solostar3%Lantus3%Part D<11 patientsGLP-1 receptor agonist17.7%Ozempic40%Mounjaro22%Trulicity19%Rybelsus19%Part D<11 patients+ 7 more classes in this area
Hormonal (systemic)
25.5%l-Thyroxine21.3%Levothyroxine Sodium73%Synthroid27%Part D≥69 patientsThyroid Hormone Synthesis Inhibitor1.3%Methimazole100%Part D<11 patients+ 3 more classes in this area
Cardiovascular
6.4%Statin4.6%Atorvastatin Calcium46%Rosuvastatin Calcium30%Simvastatin24%Part D<11 patientsACE inhibitor1.2%Lisinopril100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Similar KOLs
Other experts from the same institution or the same specialty.
Lawrence Wechsler, MD
University of Pittsburgh Medical Center
Michel Makaroun, MD
University of Pittsburgh Medical Center
David Gaieski, MD
University of Pittsburgh Medical Center
Alessandro Furlan
University of Pittsburgh Medical Center
Yousef Saleh Khader
Jordan University of Science and Technology
Jens Juul Holst
University of Copenhagen
Victor Montori, MD
Mayo Clinic
Christos Mantzoros, MD
Harvard Medical School
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”